Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors

/PRNewswire/ -- Sirnaomics Ltd. (Stock Code: 2257.HK) (the "Company", together with its subsidiaries, "Sirnaomics" or the "Group"), a leading biopharmaceutical...

Related Keywords

China ,United States ,Suzhou ,Jiangsu ,Nigel Yip ,Bunny Lee ,Alexis Feinberg ,Michael Molyneaux ,Patrick Lu ,Lysine Co ,Sirnaomics Ltd ,Prnewswire Sirnaomics Ltd ,Stock Code ,Executive Director ,Chief Medical Officer ,Histidine Lysine Co Polymer ,Financial Officer ,Media Contact ,